Enabling the future of healthcare: innovating, transforming, and adapting with PLG

Enabling the future of healthcare: innovating, transforming, and adapting with PLG

The life science value chain is facing several challenges today. Digital transformation must be driven by health authorities’ standards and societal trends. Disruptive innovation in science and technology offers unprecedented prevention, diagnosis, and treatment options. At the same time, there is a crucial need to reinvent business models to establish a sustainable, high-performance, innovative, and patient-centered healthcare system. 

As we navigate these complexities, we are ready to support you, catalyzing research innovation and development for the future. Our commitment extends to working toward a healthcare landscape that continuously adapts to meet individuals’ and society’s diverse and evolving needs. 

Digital innovation: PLG digital and AI factory for regulatory affairs business disruption

Digital innovation: PLG digital and AI factory for regulatory affairs business disruption

An integrated approach to digital innovation in life sciences, leveraging cutting-edge technologies to transform regulatory expertise into a strategic asset, delivering high-value transformation that meets regulatory requirements and exceeds industry standards. 

Healthcare and medical innovation

Healthcare and medical innovation

The innovative healthcare ecosystem holds excellent potential for patients and society. However, disruptive technologies for health raise specific questions related to safety, quality, effectiveness, and manufacturing throughout the product lifecycle. We support and develop a multidisciplinary and collaborative regulatory science approach and shared value business models to support the development of disruptive, innovative products. We are enhancing our ability to bridge the gap between disruptive technology creation and business integration to support our customers through the entire new product development journey. 

PLG’s approach to high-value innovation

PLG’s approach to high-value innovation

We have decided to fully embrace the complexity of a high-value-added innovation process by working on all available fronts, either on the methodological aspect, with its original research and development integrated (RDI) framework, or on its technical complexity by recruiting brilliant young researchers. 

In addition to its internal ecosystem, which harnesses our expertise in vital regulatory affairs domains, our organization works on dynamic collaborations within an extensive external network. This network comprises partners across private and public sectors, including innovative startups, strategic investors, esteemed academic institutions, and more. These interconnected ecosystems fortify our capacity to innovate, adapt, and support you in a continuously evolving landscape. 

KEY FIGURES

3

Months average duration to develop a proof-of-concept dedicated to a specific lock using the RDI framework.

65

Number of peer-reviewed scientific communications and publications from the R&I PLG core team.

12

Digital and regulatory science R&I projects run in 2024.

Operational research and innovation are the best ways to face our ecosystem’s challenges concretely, to be at the core of its innovation pipeline, and to stay at the frontiers of the state-of-the-art.

Gabriele Breda

PhD, Research and Innovation Director